Fulveject 250 mg/5 ml solution for injection (fulvestrant, pre-filled syringe, 5 ml)
Fulvestrant belongs to the group of estrogen blockers. Estrogens, a type of female sex hormones, can in some cases be involved in the growth of breast cancer.
Fulveject is used to treat advanced or metastatic breast cancer in postmenopausal women.
Code: L02BA03
|